Randomized, double-blind, placebo-controlled trial of aripiprazole oral solution in children and adolescents with Tourette's disorder

• Main Authors: Fan He (Author), Jie Luo (Author), Yi Huang (Author), Yunpeng Hao (Author), Ling Sun (Author), Xiaoyan Ke (Author), Bin Wu (Author), Yucai Chen (Author), Ying Han (Author), Yuebing Zhang (Author), Jing Liu (Author), Hong Han (Author), Mingji Xian (Author), Motomichi Uki (Author), Yi Zheng (Author)
• Format: Book
• Published: BMC, 2024-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Aripiprazole is the most frequently recommended antipsychotic for the treatment of tics in children and adolescents with Tourette's disorder (TD). However, to date, a randomized controlled trial for aripiprazole oral solution has not been conducted despite being widely prefe...